Companies / Lexeo Therapeutics, Inc. / Activity
Activity — Lexeo Therapeutics, Inc.
4 moves.
Top impactInsider · CEO movesInsider · biggest buysInsider · biggest sellsInstitution · biggest movesInstitution · new positions
| Date | Actor | Action | Security | Value | Shares Δ | Position after | Impact |
|---|---|---|---|---|---|---|---|
| Feb 18, 2026 | Townsend Richard Nolan CEO | Sell | Common Stock | $64.9K | -10K -2.53% | 392,483 0.48% of shares | low |
| Mar 13, 2026 | Townsend Richard Nolan CEO | Grant | Common Stock | $6.9K | +3K +0.67% | 395,106 0.48% of shares | low |
| Feb 4, 2026 | Townsend Richard Nolan CEO | Grant | Common Stock | $0 | +162K +67.08% | 402,656 0.49% of shares | low |
| Feb 4, 2026 | Townsend Richard Nolan CEO | Grant | Stock Option (right to buy) | — | +647K | 646,665 0.79% of shares | low |